The rising incidence of bacterial infections that affect the gastrointestinal tract has played a key role in driving demand within the global enteric disease testing market. The medical fraternity gives tremendous attention to new-age enteric testing technologies, mainly due to the accuracy and precision of this technique. Furthermore, use of enteric disease testing to determine the nature of microbes that have penetrated the host cells of the body has also driven market demand. Therefore, the total volume of revenues within the global enteric disease testing market is expected to increase by leaps and bounds in the coming times. As microbial studies within medicine gain popularity, new research lines are projected to come to the fore within medicine.
Request Sample Of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1258- Use of enteric disease testing to diagnose diseases related to the digestive tract and the intestinal lining has also aided market growth. There is no contention about the ills of infections such as shigella and rotavirus, and this factor has aided market growth. Enteric testing has emerged as a useful method to contain viruses after diagnosing their presence in the body. Henceforth, the use of enteric testing technologies is projected to gain momentum in the times to follow. Improvement in medical manufacturing has addressed the unmet needs of governments and local bodies, and this is an important driver of market demand.
- The recent outbreak of the novel coronavirus has created ripples across the global enteric disease testing market. The need for new and advanced testing kits, coupled with the uncontrolled increase in the number of covid-19 infections, could support the growth of the global enteric disease testing market. Therefore, the total volume of revenues within the global enteric diseases testing market is set to rise in the years to follow. Moreover, the market value of testing technologies shall trace an ascending trajectory in the times to follow.
Global Enteric Disease Testing Market: Snapshot
Enteric diseases are gastrointestinal infections caused by microbes such as bacteria, viruses, and parasites when they enter the body through the mouth or intestinal systems. Various microbes responsible for enteric infections include salmonella, shigella, rotavirus, norovirus, c. difficile, cryptosporidium, vibrio, and campylobacter. These diseases may range from asymptomatic to having mild to severe symptoms such as abdominal cramps, bloody diarrhea, stool containing blood or pus, fever, and weight loss. Incubation period varies from few days to few weeks depending on the disease and severity. In order to reduce the chance of developing complications, these diseases need to be diagnosed early.
The global enteric disease testing market was valued at US$3.7 bn in 2017 and is likely to rise to US$4.9 bn by 2025, exhibiting a steady 3.6% CAGR therein.
Bacterial Enteric Diseases to Dominate Demand from Global Market
The global market for enteric disease testing has been segmented broadly on the basis of different pathogens causing enteric illness, namely bacteria, viruses, and parasites. The market is further segmented into various diseases caused by respective pathogens, such as salmonellosis, shigellosis, and campylobacteriosis, caused by enteric bacteria. Leading viral and parasitic enteric diseases include norovirus and rotavirus infections, giardiasis, amebiasis, and cryptosporidiosis. Key testing methods in the global enteric disease testing market include immunoassay testing, conventional testing, and molecular diagnostic testing. Further, the market has been segmented according to end use into hospitals, diagnostic laboratories, and physician offices.
Based on disease indication, bacterial enteric diseases accounted for approximately 58.5% of the global enteric disease testing market in 2016. Product developments that enable smooth and fast procedures for both physicians and patients and the growing incidence of diseases associated with E. coli and C. difficile are expected to fuel the growth of the bacterial enteric disease segment. The parasitic enteric disease segment is the second leading revenue generator for the global enteric disease testing market. In developed regions, frequent traveling to developing nations has become a major factor driving the segment’s growth.
Request For Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1258
Failure to Capitalize on High Potential of Asia Pacific Market could Cost Enteric Disease Testing Market Players
By geography, the global enteric disease testing market has been divided into five major regions: North America, Europe, Asia, Latin America, and the Middle East and Africa. North America and Europe accounted for the highest share of the global enteric disease testing market in 2017, followed by Asia Pacific, Latin America, and the Middle East and Africa. The U.S. dominated the enteric disease testing market in North America, accounting for around 94.0% of the latter in 2016. This dominance is majorly due factors such as high costs of products and high level of consumer awareness. The enteric disease testing market was valued at more than US$1 bn in both North America and Europe in 2017 and is likely to rise to more than US$1.4 bn by 2025, with Europe leading the way with a robust 4.7% CAGR.
Asia Pacific, accounting for more than 50% of the total global population, represents a profitable market for enteric disease testing in terms of growth and potential. The region is associated with unsafe drinking water, poor sanitation, and unhygienic conditions, and thus witnesses a large percentage of population infected with enteric microbes. The market for enteric disease testing is primarily driven in this region due to the high prevalence of enteric infections, rising awareness, inception of rapid diagnostic tests and continuously improving economy of India and China, leading to increased healthcare expenditure.
Request the Coronavirus Impact Analysis across Industries and Markets - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1258
The key players operating in the enteric disease testing market are Trinity Biotech plc, Biomerica, Inc., Bio-Rad Laboratories, Inc., Alere Inc., Biomerieux SA, Meridian Bioscience Inc., CorisBioconcept SPRL, Quest Diagnostics Incorporated, Cepheid Inc., and DiaSorin.
More Trending Reports by Transparency Market Research – https://www.biospace.com/article/diabetic-foot-ulcers-treatment-market-surge-in-number-of-amputations-due-to-diabetic-foot-ulcers-to-propel-the-market/
No comments:
Post a Comment